|
⚲
|
| Abingworth BioVentures V LP | |
|---|---|
| Firm |
Carlyle Investment Management LLC
✚
|
| Fund # | 805-4953602524 |
| CIK # | |
| Sale | |
| Fund | Private Equity Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | General Partner Abingworth General Partner V LLP, Abingworth General Partner V LLP |
| Custodian | State Street Trustees Limited, Sanne Fiduciary Services UK Limited, Apex Group |
| Auditor | Deloitte LLP, Ernst & Young LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Synergetics, Inc.
✚
|
0.0 | |
|
Synoligo Biotechnologies, Inc.
✚
|
0.0 | |
|
T3D Therapeutics, Inc.
✚
|
0.0 | |
|
T3 Engineering Corp
✚
|
0.0 | |
|
T3 Holdings Inc
✚
|
0.0 | |
|
TabacaleraYsidron, Inc.
✚
|
0.0 | |
|
Taconic Group, LLC
✚
|
0.0 | |
|
Tactical Opportunities Portfolio 2022 LP
✚
|
0.0 | |
|
Synder Jessica E.
✚
|
0.0 | |
|
Magic Spoon Inc.
✚
|
0.0 |